These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 4026796)

  • 1. Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange.
    Gahl WA; Tietze F; Butler JD; Schulman JD
    Biochem J; 1985 Jun; 228(3):545-50. PubMed ID: 4026796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystine depletion by WR-1065 in cystinotic cells. Mechanism of action.
    Butler JD; Gahl WA; Tietze F
    Biochem Pharmacol; 1985 Jun; 34(12):2179-85. PubMed ID: 2988568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions.
    Gahl WA; Tietze F; Bashan N; Bernardini I; Raiford D; Schulman JD
    Biochem J; 1983 Nov; 216(2):393-400. PubMed ID: 6661204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cysteamine and other thiols on cystine egress from isolated lysosome-rich fractions of cystinotic and normal leucocytes.
    Steinherz R; Tietze F; Schulman JD
    Clin Chim Acta; 1983 Jul; 132(1):17-22. PubMed ID: 6616859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide.
    Butler JD; Zatz M
    J Clin Invest; 1984 Aug; 74(2):411-6. PubMed ID: 6746900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired clearance of free cystine from lysosome-enriched granular fractions of I-cell-disease fibroblasts.
    Tietze F; Rome LH; Butler JD; Harper GS; Gahl WA
    Biochem J; 1986 Jul; 237(1):9-15. PubMed ID: 3800891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of cystine in cystinotic fibroblasts by homocysteine. Synergism of cysteamine with various reducing agents in depletion of cystine from cystinotic fibroblasts.
    Butler JD
    Biochem Pharmacol; 1990 Aug; 40(4):879-85. PubMed ID: 2386552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Handling of L-[35S]cystine by cysteamine-pretreated cystinotic and normal fibroblasts.
    States B; Lee J; Segal S
    Arch Biochem Biophys; 1983 Feb; 220(2):361-9. PubMed ID: 6824329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysosomal cystine storage in cystinosis and mucolipidosis type II.
    Greene AA; Jonas AJ; Harms E; Smith ML; Pellett OL; Bump EA; Miller AL; Schneider JA
    Pediatr Res; 1985 Nov; 19(11):1170-4. PubMed ID: 4069825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester.
    Steinherz R; Tietze F; Gahl WA; Triche TJ; Chiang H; Modesti A; Schulman JD
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4446-50. PubMed ID: 6956873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ions and ionophores on cystine egress from human leucocyte lysosome-rich granular fraction.
    Bashan N; Gahl WA; Tietze F; Bernardini I; Schulman JD
    Biochim Biophys Acta; 1984 Nov; 777(2):267-73. PubMed ID: 6487629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes.
    Gahl WA; Tietze F; Bashan N; Steinherz R; Schulman JD
    J Biol Chem; 1982 Aug; 257(16):9570-5. PubMed ID: 7107582
    [No Abstract]   [Full Text] [Related]  

  • 13. Lysosomal cystine transport in cystinosis variants and their parents.
    Gahl WA; Tietze F
    Pediatr Res; 1987 Feb; 21(2):193-6. PubMed ID: 3822600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.
    Hector E; Cairns D; Michael Wall G
    Orphanet J Rare Dis; 2022 Jun; 17(1):231. PubMed ID: 35710564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystine accumulation and loss in normal, heterozygous, and cystinotic fibroblasts.
    Jonas AJ; Greene AA; Smith ML; Schneider JA
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4442-5. PubMed ID: 6956872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of mercaptoethylgluconamide for depleting human cystinotic fibroblasts of their accumulated lysosomal cystine.
    Pisoni RL; Lisowski KM; Lemons RM; Thoene JG
    Pediatr Res; 1989 Jul; 26(1):73-6. PubMed ID: 2771512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of cystine reaccumulation by cystinotic fibroblasts in vitro.
    Forster S; Scarlett L; Lloyd JB
    Biosci Rep; 1990 Apr; 10(2):225-9. PubMed ID: 2357486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystine accumulation and clearance in normal and cystinotic fibroblasts exposed to cystine dimethyl ester.
    Steinherz R; Makov N; Narinsky R; Meidan B; Kohn G
    Clin Chim Acta; 1984 Aug; 141(2-3):119-25. PubMed ID: 6488551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selenium compounds on selenium content, growth and 35S-cystine metabolism of skin fibroblasts from normal and cystinotic individuals.
    Rhead WJ; Schneider JA
    Bioinorg Chem; 1976; 6(3):187-202. PubMed ID: 1053514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the low beta-galactosidase activity in cystinotic fibroblasts: effects of cysteamine.
    Kooistra T; Lloyd JB
    Clin Chim Acta; 1985 Jan; 145(1):9-16. PubMed ID: 3919971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.